Is This Stock A Vertex Pharma Clone?

By: via Benzinga
In a report published Friday, Deutsche Bank analysts maintained a Buy rating on PTC Therapeutics, Inc (NASDAQ: PTCT), while raising ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.